Prevention of carotid artery thrombosis after oral administration of the glycoprotein IIb/IIIa antagonist CRL42796HENNAN, James K; WILLENS, David E; DRISCOLL, Edward M et al.Journal of cardiovascular pharmacology. 2003, Vol 42, Num 1, pp 71-77, issn 0160-2446, 7 p.Article

The status of new anticoagulantsBATES, Shannon M; WEITZ, Jeffrey I.British journal of haematology. 2006, Vol 134, Num 1, pp 3-19, issn 0007-1048, 17 p.Article

Monitoring the new antithrombotic drugsWALENGA, Jeanine M; HOPPENSTEADT, Debra A.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 683-695, issn 0094-6176, 13 p.Conference Paper

Update on Antithrombotic Therapy New AnticoagulantsEIKELBOOM, John W; WEITZ, Jeffrey I.Circulation (New York, N.Y.). 2010, Vol 121, Num 13, pp 1523-1532, issn 0009-7322, 10 p.Article

Antithrombotic therapy in hypertension: a Cochrane Systematic reviewFELMEDEN, D. C; LIP, G. Y. H.Journal of human hypertension. 2005, Vol 19, Num 3, pp 185-196, issn 0950-9240, 12 p.Article

Emerging anticoagulant drugsBATES, Shannon M; WEITZ, Jeffrey I.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 9, pp 1491-1500, issn 1079-5642, 10 p.Article

Exploration of the Antiplatelet Activity Profile of Betulinic Acid on Human PlateletsTZAKOS, Andreas G; KONTOGIANNI, Vassiliki G; TSOUMANI, Maria et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 28, pp 6977-6983, issn 0021-8561, 7 p.Article

Antithrombotiques et gestes invasifsMOTTIER, Dominique.MT. Médecine thérapeutique. 2007, Vol 12, issn 1264-6520, 80 p., NSSerial Issue

Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?GREER, Ian A; BRENNER, Benjamin; GRIS, Jean-Christophe et al.British journal of haematology. 2014, Vol 165, Num 5, pp 585-599, issn 0007-1048, 15 p.Article

Quality of Life in Children Requiring Antithrombotic Therapy: Development of a MeasureBRUCE, Aisha A. K; BAUMAN, Mary E; MASSICOTTE, M. Patricia et al.Seminars in thrombosis and hemostasis. 2011, Vol 37, Num 7, pp 834-839, issn 0094-6176, 6 p.Article

¿Está indicada la profilaxis antitrombótica en el paciente oncológico terminal? = Is antithrombotic prophylaxis indicated for cancer patients at the end of life?BENGOETXEA MARTINEZ, I; ONAINDIA EZENARRO, J; BENGOETXEA PENA, I et al.Medicina paliativa. 2009, Vol 16, Num 4, pp 240-243, issn 1134-248X, 4 p.Article

Effects of GP IIb/IIIa receptor inhibitor tirofiban (Aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosisRUKSHIN, Vladimir; AZARBAL, Babak; FINKELSTEIN, Ariel et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 4, pp 615-624, issn 0160-2446, 10 p.Article

Treatment of Venous ThromboembolismMERLI, Geno J.The American journal of medicine. 2008, Vol 121, Num 11A, issn 0002-9343, S2-S9, SUPConference Paper

Treatment of Venous ThromboembolismWELLS, Philip S; FORGIE, Melissa A; RODGER, Marc A et al.JAMA, the journal of the American Medical Association. 2014, Vol 311, Num 7, pp 717-728, issn 0098-7484, 12 p.Article

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched studyHAMON, Martial; RAO, Sunil V; STEG, Gabriel et al.EuroIntervention. 2012, Vol 8, Num 4, pp 486-492, issn 1774-024X, 7 p.Article

Synthesis of a stable-isotope-labeled biotinylated pentasaccharide conjugate (EP217609), a dual-effect anticoagulant drugRICHARD, Sébastien; AHMED EL HADRI; SCHREUDER GOEDHEIJT, Marcel et al.Journal of labelled compounds & radiopharmaceuticals. 2011, Vol 54, Num 9-10, pp 637-644, issn 0362-4803, 8 p.Article

Low-molecular-weight heparin in oncologyZACHARSKI, Leo R; LOYNES, James T.Anticancer research. 2003, Vol 23, Num 3C, pp 2789-2793, issn 0250-7005, 5 p.Article

Integrated pharmacokinetic/pharmacodynamic model of XV459, a potent and specific GPIIb/IIIa inhibitor, in healthy male volunteersFOSSLER, Michael J; EBLING, William F; MA, Su et al.Journal of clinical pharmacology. 2002, Vol 42, Num 12, pp 1326-1334, issn 0091-2700, 9 p.Article

Oral Anticoagulation in Elderly Adults with Atrial Fibrillation: Integrating New Options with Old ConceptsZARRAGA, Ignatius Gerardo E; KRON, Jack.Journal of the American Geriatrics Society. 2013, Vol 61, Num 1, pp 143-150, issn 0002-8614, 8 p.Article

An Antithrombotic Fucoidan, Unlike Heparin, Does Not Prolong Bleeding Time in a Murine Arterial Thrombosis Model: A Comparative Study of Undaria pinnatifida sporophylls and Fucus vesiculosusMIN, Soon-Ki; KWON, Oh-Choon; LEE, Sub et al.PTR. Phytotherapy research. 2012, Vol 26, Num 5, pp 752-757, issn 0951-418X, 6 p.Article

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trialMAKI, Dennis G; ASH, Stephen R; WINGER, Roland K et al.Critical care medicine. 2011, Vol 39, Num 4, pp 613-620, issn 0090-3493, 8 p.Article

Delivery of Optimized Anticoagulant Therapy : Consensus Statement from the Anticoagulation ForumGARCIA, David A; WITT, Daniel M; BECKER, Richard C et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 7-8, pp 979-988, issn 1060-0280, 10 p.Article

Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyWARKENTIN, Theodore E; GREINACHER, Andreas.Chest. 2004, Vol 126, Num 3, pp 311S-337S, issn 0012-3692, SUPConference Paper

LXR as a novel antithrombotic targetSPYRIDON, Michael; MORAES, Leonardo A; JONES, Chris I et al.Blood. 2011, Vol 117, Num 21, pp 5751-5761, issn 0006-4971, 11 p.Article

New Antithrombotic DrugsGROSS, P. L; WEITZ, J. I.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 2, pp 139-146, issn 0009-9236, 8 p.Article